Wednesday, March 13, 2019
The 2019 V-BID Summit invites stakeholders to engage in a highly interactive all-day discussion to address the opportunities and challenges that arise from the conceptual design to the implementation of clinically nuanced payment reform and benefit design strategies across some of today’s most relevant and challenging health care topics.
Sessions include:
- Expanded Role of V-BID in Medicare Advantage and Commercial Plans
- Removing Low-Value Services to Create ‘Headroom’ for High-Value Care
- Innovative Approaches to Finance High-Cost, High-Value Services
- V-BID X: A Novel Plan Design to Lower Premiums and Improve Coverage of High-Value Care
Tuesday, March 12, 2019
Jack Roth Stadium Club at “The Big House”
5:30-7:00 pm | Welcome Reception
7:00-8:30 pm | Dinner
Wednesday, March 13, 2019
Jack Roth Stadium Club at “The Big House”
7:30-8:15 am | Continental Breakfast
8:15-8:30 am | Welcome & Opening Remarks
8:30-10:00 am | Session 1: Expanded Role of V-BID in Medicare Advantage and Commercial Plans
Speakers:
- Mark Atalla, Center for Medicare and Medicaid Innovation
- Melanie Egorin, U.S. House Ways and Means Committee
- Stephen Parente, University of Minnesota
Moderator: Cliff Goodman, Lewin Group
10:00-10:15 am | Break
10:15-11:45 am | Session 2: Removing Low-Value Services to Create ‘Headroom’ for High-Value Care
Speakers:
- Daniel Carey, Commonwealth of Virginia
- Gwen Darien, National Patient Advocate Foundation
- John Keats, Cigna
Moderator: Cliff Goodman, Lewin Group
11:45 am-1:00 pm | Networking Lunch/Break
12:00 – 12:45 pm | Stadium Tours Available
1:00 pm-2:30 pm | Session 3: Innovative Approaches to Finance High-Cost, High-Value Services
Speakers:
- Daniel Klein, Patient Access Network
- Ted Okon, Community Oncology Alliance
Moderator: Cliff Goodman, Lewin Group
2:30-2:45 pm | Break
2:45-4:15 pm | Session 4: V-BID X: A Novel Plan Design to Lower Premiums and Improve Coverage of High-Value Care
Speakers:
- Michael Chernew, Harvard Medical School
- Greg Gierer, AHIP
- Lourdes Grindal Miller, Centers for Medicare & Medicaid Services
Moderator: Cliff Goodman, Lewin Group
4:15-4:30 pm | Closing Remarks
MARK ATALLA, Ph.D., leads the Medicare Advantage Value-Based Insurance Design Model and Part D Payment Modernization Model at the Center for Medicare and Medicaid Innovation (CMMI) at the Centers for Medicare and Medicaid Services (CMS). At CMMI, Mark has led Medicare Advantage and Part D innovation, and has supported the Enhanced Medication Therapy Management and Next Generation Accountable Care Organization models. Prior to coming to CMMI, Mark was the Director of Pharmacy at Fresenius Medical Care and a managing pharmacist at the pharmacy benefit managers Medco and Express Scripts. Mark has a Doctor of Pharmacy from the University of Florida and a Master of Business Administration from Yale University.
DANIEL CAREY, M.D. was appointed Secretary of Health and Human Resources by Governor Ralph Northam in January 2018. Prior to his appointment, Dr. Carey worked for over 20 years as a cardiologist in Lynchburg and served as Senior Vice President and Chief Medical Officer of Centra, where his responsibilities included information technology services, patient quality and safety efforts, performance improvement initiatives, and functions of the medical staff at Centra’s 3 acute care facilities.
MICHAEL CHERNEW, Ph.D., is the Leonard D. Schaeffer Professor of Health Care Policy and the Director of the Healthcare Markets and Regulation (HMR) Lab in the Department of Health Care Policy at Harvard Medical School. Dr. Chernew’s research activities focus on innovations in payment reform and benefit design. Dr. Chernew is the former Vice Chair of the Medicare Payment Advisory Commission. Dr. Chernew serves as Co-Editor of the American Journal of Managed Care and Editor for the Journal of Health Economics. In 2010, he was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Chernew earned his undergraduate degree from the University of Pennsylvania and a doctorate in economics from Stanford University.
GWEN DARIEN is a longtime patient advocate who has played leadership roles in some of the country’s preeminent nonprofit organizations. As executive vice president for patient advocacy and engagement at the National Patient Advocate Foundation and the Patient Advocate Foundation, Gwen leads programs that link PAF’s patient service programs to NPAF initiatives, with the goal of improving access to equitable, affordable, quality health care.
As a three-time cancer survivor herself, Gwen came into cancer advocacy expressly to change the experiences and outcomes for the patients who came after her and to change the public dialogue about cancer and other life-threatening illnesses. Gwen is a graduate of Sarah Lawrence College, where she also served as an advisor for their Health Advocacy program.
MELANIE EGORIN, Ph.D., has over 20 years of health policy experience with 15 years in the federal government. Melanie is the Deputy Staff Director for the Health Subcommittee of the Committee on Ways and Means in the U.S. House of Representatives. She is the lead staff person for Affordable Care Act policy as well as Medicare Advantage, dual-eligible beneficiaries, end-stage renal disease, women’s health, and health tax issues. Prior to joining Ways and Means, Melanie worked for the U.S. Government Accountability Office (GAO). Melanie went to Emory University for her undergraduate and master’s degree and University of California San Francisco for her Ph.D.
A. Mark Fendrick, M.D., is a Professor of Internal Medicine and a Professor of Health Management and Policy at the University of Michigan.
Dr. Fendrick conceptualized and coined the term Value-Based Insurance Design (V-BID) and currently directs the V-BID Center at the University of Michigan, the leading advocate for development, implementation, and evaluation of innovative health benefit plans. His research focuses on how clinician payment and consumer engagement initiatives impact access to care, quality of care, health care disparities, and health care costs.
GREGORY GIERER is the Senior Vice President for Policy at America’s Health Insurance Plans (AHIP) where he leads policy development work on legislative and regulatory policy issues—with a primary focus on health reform implementation and private insurance market reforms. Mr. Gierer has over 15 years of experience with health care policy and analysis. Prior to joining AHIP, he served as a Senior Director for Policy at the Pharmaceutical Research and Manufacturers of America (PhRMA) where he worked on developing and managing public policy issues related to comprehensive health care reform, health-system and delivery reforms, and public programs such as Medicaid and the Children’s Health Insurance Program (CHIP). He previously served as a Senior Policy Consultant at the Blue Cross and Blue Shield Association (BCBSA) and a Policy Analyst at America’s Health Insurance Plans (AHIP).
CLIFFORD GOODMAN, Ph.D, is a Senior Vice President at The Lewin Group, a health care policy consulting firm based in Falls Church, Virginia. Dr. Goodman has 30 years of experience in such areas as health technology assessment, evidence-based health care, comparative effectiveness research, and payment. He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups. His recent work has involved such areas as oncology, cardiovascular disease, diabetes, blood disorders, obesity, end-stage renal disease, HIV/AIDS, follow-on biologics, diagnostic testing, pharmacogenomics, personalized medicine, and organ donation and transplantation. Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, health industry advisory boards, and workshops. Dr. Goodman served as Chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDPAC, 2009-12) for the US Centers for Medicare and Medicaid Services. He served as President of the professional society Health Technology Assessment international (HTAi, 2001-13), and is a Fellow of the American Institute for Medical and Biological Engineering. He received a Ph.D. from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University.
Lourdes Grindal-Miller is the Director of the Marketplace Plan Management Group at the Centers for Medicare & Medicaid Services (CMS). She has been with CMS since 2002. Leading up to the ACA, Lourdes worked 8 years in CMS in the area of fraud, waste and abuse in Medicare and Medicaid. Prior to CMS, Ms. Grindal Miller spent two years in Honduras as a Peace Corps Volunteer.
JOHN KEATS, MD serves as Cigna’s National Medical Senior Director for Enterprise Trend Analysis and Specialty Society Relationships.
A practicing Obstetrician and Fellow of the American College of Obstetricians and Gynecologists (ACOG), Dr. Keats is the course director for ACOG’s post-graduate course entitled Quality and Safety for Leaders in Women’s Health Care. In addition, he serves as a site reviewer for ACOG’s Voluntary Review of Quality of Care program and is a member of that program’s national steering committee. Dr. Keats is an ex-officio member of ACOG’s national Patient Safety and Quality Improvement Committee. He received his MD from Brown University and completed a residency in Obstetrics and Gynecology at UCLA Medical Center.
DAN KLEIN brings over 35 years of executive leadership in healthcare and information technology services to the PAN Foundation. His mission at PAN is twofold—1) to help seriously ill people get access to the care they need by providing grants to pay for their deductibles, copayments and coinsurance; and 2) to advocate for more systemic and sustainable ways to reduce out-of-pocket costs and make treatment more affordable for people with life-threatening, chronic and rare diseases by lowering out-of-pocket costs.
Since joining the PAN Foundation in 2014, Mr. Klein has expanded PAN’s capacity to help the growing number of patients who need financial assistance, strengthened PAN’s compliance program to ensure that PAN continues to fulfill its mission in strict compliance with regulations, and implemented new technology to enhance the patient experience and to better support the needs of healthcare providers and pharmacists.
Mr. Klein previously served as Senior Vice President for the Cystic Fibrosis Services specialty pharmacy and then as Senior Vice President for Patient Access Programs at the Cystic Fibrosis (CF) Foundation. His leadership at the CF Foundation led to the steady growth and eventual sale of the CF Services pharmacy to Walgreens. He also launched the CF Patient Assistance Foundation, which provided financial assistance and case management services to underinsured patients living with cystic fibrosis.
In addition to his leadership in patient assistance, Mr. Klein has served as Chairman and Chief Executive Officer of Panurgy Corporation, a leading mid-market information technology services company, and as a consultant on health promotion and health planning to the U.S. Department of Health and Human Services and the Pan American Health Organization, respectively.
TED OKON is a nationally recognized expert on the policy and politics of cancer care. He is quoted extensively in the press, including guest appearances on TV and radio news shows. Ted has testified before Congress on cancer issues and is frequently on Capitol Hill discussing the nation’s cancer care delivery system. Ted’s target areas of expertise include the cost of cancer treatment, health care reform, Medicare reimbursement, drug shortages, and the changing landscape of cancer care delivery in the United States.
Ted has dedicated his career to healthcare business and policy. He has worked for several pharmaceutical companies including Merck and Warner Lambert, now part of Pfizer, and IMS Health. He co-founded and took public the health care information business Medical Marketing Group. He also founded two oncology companies and has traveled extensively to China, India, Singapore, the U.K., and the Middle East, analyzing and discussing cancer care delivery.
As executive director of the Community Oncology Alliance (COA), Ted oversees the strategic direction of this non-profit organization dedicated to patients and providers in the community cancer care setting, under the direction of a dedicated board of oncologists and practice administrators. Ted also travels the country speaking to state oncology societies, professional organizations, and companies about the challenges facing the nation’s cancer care delivery system. He has authored numerous articles and studies relating to cancer care policy and politics, reimbursement, and clinical issues.
Ted holds a BS degree from Fairfield University and an MBA from the Carnegie-Mellon University Tepper School of Business. His wife is a full-time practicing oncology nurse.
STEPHEN T. PARENTE, PhD, MPH, MS is the Minnesota Insurance Industry Chair of Health Finance in Carlson School of Management and the Director of the Global Medical Valuation Laboratory at the University of Minnesota. His academic and policy work specializes in health economics, health information technology, and health insurance. In Washington DC, he served as the Governing Chair of the Health Care Cost Institute, an Adjunct Scholar of the American Enterprise Institute and a health policy adviser to the American Action Forum. He has a doctorate from Johns Hopkins University and both a Masters of Public Health and a Masters of Public Policy Analysis from the University of Rochester.
All Summit events will take place at the Jack Roth Stadium Club at the U-M Stadium, located at 1201 South Main Street, Ann Arbor, MI. Detailed logistics can be found below.
Hotel Information: The Kensington Hotel
Registrants for the 2019 V-BID Summit can receive a special discounted room rate of $115, plus taxes, at The Kensington Hotel at 3500 South State Street in Ann Arbor, MI. Reservations made after Tuesday, February 12th are subject to availability.
When making a reservation, you must identify yourself as being with the “U of M V-BID Center Summit” in order to receive the discounted rate.
Click here to make a reservation online, or call the in-house reservation line at 734-761-7800.
Click here for a complete list of hotels in the Ann Arbor area.
Air Travel
Detroit International Airport (DTW) is the closest airport to Ann Arbor. Travel time from DTW to Ann Arbor is approximately 25 minutes.
Ground Transportation
Shuttles
Tuesday, March 12th: Welcome/Reception Dinner
5pm pick-up at Kengsington Hotel, drop-off at Jack Roth Stadium Club
8:30pm pick-up at Jack Roth Stadium Club, drop-off at Kensington Hotel
Wednesday, March 13th: V-BID Summit
7:15am pick-up at Kengsington Hotel, drop-off at Jack Roth Stadium Club
4:45pm pick-up at Jack Roth Stadium Club, drop-off at DTW
Limousines & Car Services
- Ann Arbor Metro Airport Cars: (734) 507-9220
- A2 Area Metro Ride: (734) 994-5984
- A-1 Airport Cars: (734) 642-0010
- Blue Cab Co.: (734) 547-2222
- Golden Limousine: 1-800-300-5151
- Metro Cars: (800) 456-1701
- Yellow Cab/Select Ride: (734) 663-3355 (offers shared shuttle service for half price)
Uber and Lyft are also available (one-way fare approx. $35).
AirRide
This public transportation service offers near-hourly service between DTW and Ann Arbor. Fares are $12 each way with advance reservation. Boarding/pick-up locations are at The Kensington Court Hotel and Blake Transit Center. For schedules and reservations, visit MyAirRide.com.
Susan Lynne Oesterle
Program Manager & Summit Contact
Office (734) 615-9635
TEXT (734) 604-5304
For assistance or additional information, please email vbidcenter@umich.edu or call (734) 615-9635.
We look forward to welcoming you to Ann Arbor!
2019 V-BID Summit
Sponsorship Opportunities
The 2019 V-BID Summit will be held as a two-day event at the University of Michigan on March 12/13.
The Summit invites stakeholders to engage in a highly interactive all-day discussion to address the opportunities and challenges that arise from the conceptual design to the implementation of clinically nuanced payment reform and benefit design strategies across some of today’s most relevant and challenging health care topics. A draft agenda will soon be available for dissemination.
All donations/sponsorships will be gratefully accepted, including amounts lower and higher than those listed below. Special consideration will be given to non-profit organizations. For more information, please contact Susan Lynne Oesterle at 734-615-9635 or sloester@umich.edu.
Platinum sponsorship
Platinum sponsorship includes six invitations to the following:
- V-BID Summit evening reception
- Evening welcome dinner
- Networking breakfast
- Summit discussions
- Networking lunch
Platinum sponsorship recognition includes:
- Full page recognition in event program
- Logo prominently featured on event website
- Premium logo placement on event signage
Gold sponsorship
Gold sponsorship includes four invitations to the following:
- V-BID Summit evening reception
- Evening welcome dinner
- Networking breakfast
- Summit discussions
- Networking lunch
Gold sponsorship recognition includes:
- Half-page recognition in event program
- Logo featured on event website
- Prominent logo placement on event signage
Silver sponsorship
Silver sponsorship includes two invitations to the following:
- V-BID Summit evening reception
- Evening welcome dinner
- Networking breakfast
- Summit discussions
- Networking lunch
Silver sponsorship recognition includes:
- Recognition in event program
- Logo featured on event website
- Logo featured on event signage
Bronze sponsorship
Bronze sponsorship includes one invitation to the following:
- V-BID Summit evening reception
- Evening welcome dinner
- Networking breakfast
- Summit discussions
- Networking lunch
Bronze sponsorship recognition includes:
- Recognition in event program
- Logo included on event website
- Logo included on event signage
The V-BID Center has a myriad of resources available to add context to our sessions
Session 1: Expanded Role of V-BID in Medicare Advantage and Commercial Plans
- The V-BID Center’s Medicare Advantage Initiative
- Medicare Advantage Infographic
- Medicare Advantage 1-pager
- History of V-BID in Medicare Advantage Timeline
Session 2: Removing Low-Value Services to Create ‘Headroom’ for High-Value Care
- The V-BID Center’s Precision Patient Assistance Initiative
- Patient Assistance Infographic
- Precision Co-Pay Assistance Brief and Video
- The V-BID Center’s Low-Value Care Initiative
- Low-Value Care Infographic
- “Top Five” Infographic
Session 3: Innovative Approaches to Finance High-Cost, High-Value Services
- The V-BID Center’s Precision Medicine Needs Precision Benefit Design Initiative
- Precision Medicine Infographic
- Precision Medicine Whiteboard Video
- The V-BID Center’s Precision Patient Assistance initiative
- Patient Assistance Infographic
- Precision Co-Pay Assistance Brief and Video
- The V-BID Center’s Low-Value Care initiative
- Low-Value Care Infographic
- “Top Five” Infographic
Session 4: V-BID X: A Novel Plan Design to Lower Premiums and Improve Coverage of High-Value Care
- The V-BID Center’s Drug Price Iceberg Initiative
- Drug Price Iceberg Infographic
- Drug Price Iceberg 1-pager
- Drug Price Iceberg Presentation